Skip to content

    Verrica Pharmaceuticals (VRCA) stock price & financials

    View VRCA earnings calls

    Overview

    Price

    Market Cap

    Sector

    Rank

    Performance+0.5% 1Y

    Financials

    Income Statement

    Financial Trajectories

    11
    Quarterly
    MetricQ3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Trend
    EarningsRevenue
    -$1.78M
    $344.0K
    $3.44M
    $12.70M
    $14.34M
    $5.09M
    +1380.2%
    $5.02M
    +46.1%
    $5.86M
    -53.8%
    Strengthening
    Operating Profit
    -$20.70M
    -$11.41M
    -$8.13M
    $1.51M
    $1.63M
    -$7.19M
    +37.0%
    -$9.71M
    -19.5%
    -$13.10M
    -967.4%
    Weakening
    Net Profit
    -$22.86M
    -$16.20M
    -$9.74M
    $204.0K
    -$274.0K
    +98.8%
    -$8.07M
    +50.2%
    -$9.68M
    +0.6%
    -$13.15M
    -6547.5%
    Weakening
    EPS
    $-4.88
    $-1.03
    $0.02
    $-0.03
    +99.4%
    $-0.45
    +56.3%
    $-0.62
    -3200.0%
    Weakening
    Other Income
    -$2.16M
    -$4.79M
    -$1.61M
    -$1.31M
    -$1.90M
    +11.8%
    -$882.0K
    +81.6%
    $33.0K
    -$56.0K
    +95.7%
    Strengthening
    Interest
    $2.38M
    $2.35M
    $2.20M
    $2.13M
    $2.09M
    -11.9%
    $1.31M
    -44.1%
    $160.0K
    -92.7%
    $164.0K
    -92.3%
    Weakening
    Depreciation
    Profit before Tax
    MarginsOPM
    1162.5%
    -3316.9%
    -236.4%
    11.9%
    11.3%
    -99.0%
    -141.2%
    +95.7%
    -193.4%
    +18.2%
    -223.4%
    -1979.1%
    Weakening
    Tax
    ReturnsROIC
    6.6%
    4.7%
    2.8%
    -0.1%
    0.1%
    -98.8%
    2.3%
    -50.2%
    2.8%
    -0.6%
    3.8%
    Weakening

    Balance Sheet

    Balance Sheet

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    AssetsCash & Equivalents$10.27M$9.24M$10.69M$15.75M$34.27M$69.55M$46.33M$30.15M$11.20M
    Short-Term Investments
    Total Current Assets$91.15M$64.98M$67.65M$74.33M$39.12M$77.53M$51.18M$42.54M$32.64M
    Net PP&E$255.0K$2.20M$4.94M$5.50M$5.33M$2.21M$1.43M$749.0K$561.0K
    Goodwill
    Intangibles
    Total Assets$91.91M$68.42M$74.15M$80.13M$44.72M$81.60M$54.13M$47.13M$36.02M
    LiabilitiesTotal Current Liabilities$2.48M$3.35M$39.48M$46.05M$3.46M$17.02M$29.01M$16.44M$22.44M
    Short-Term Debt$35.31M$41.69M$0$0$12.94M$0
    Long-Term Debt$0$42.87M$30.98M$0
    Long-Term Leases$58.0K$1.69M$1.45M$1.23M$910.0K$583.0K$242.0K$61.0K
    Total Liabilities$2.48M$3.41M$41.17M$47.52M$4.69M$61.83M$63.99M$22.39M$31.71M
    EquityCommon Stock & APIC$3.0K$3.0K$3.0K$3.0K$4.0K$4.0K$1.0K$2.0K$2.0K
    Retained Earnings-$33.08M-$61.19M-$103.89M-$138.97M-$163.45M-$230.45M-$307.03M-$324.91M-$347.75M
    Total Equity$89.43M$65.02M$32.99M$32.60M$40.03M$19.76M-$9.86M$24.74M$4.31M
    HighlightsNet Cash / (Debt)$34.27M$26.67M$2.41M$30.15M

    Cash Flow

    Cash Flow

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    ActivitiesCash from Operating-$17.87M-$27.41M-$30.21M-$27.58M-$18.65M-$38.58M-$60.93M-$17.63M-$13.35M
    Cash from Investing-$79.89M$25.95M-$3.58M-$998.0K$54.04M-$362.0K-$19.0K$0$0
    Cash from Financing$99.38M$423.0K$35.23M$33.65M-$16.87M$74.21M$37.73M$1.45M$9.41M
    SummaryCapital Expenditure-$774.0K-$682.0K-$1.47M-$883.0K-$302.0K-$362.0K-$27.0K$0
    Free Cash Flow-$18.65M-$28.09M-$31.68M-$28.46M-$18.95M-$38.94M-$60.95M-$17.63M
    FCF Margin-237.2%-209.8%-759.9%-805.6%-49.5%

    Ratios